IMPA1-derived inositol maintains stemness in castration-resistant prostate cancer via IMPDH2 activation
Che-Chia Hsu(Atrium Health Wake Forest Baptist), Hui‐Kuan Lin(Duke University), Jiaoti Huang(Space Science Institute), Andrew J. Armstrong(Duke University), Xiaobo Zhou(The University of Texas Health Science Center at Houston), Zhong‐Zhu Chen(Target (United States)), Vasudevarao Penugurti(Atrium Health Wake Forest Baptist), Gagan Deep(Atrium Health Wake Forest Baptist), Tingjin Chen(Sun Yat-sen University), Chien‐Feng Li(National Sun Yat-sen University), Danni Peng(Nanyang Technological University), Bo‐Syong Pan(Atrium Health Wake Forest Baptist), Hongyu Li(Guiyang Medical University), Xian Zhang(Xuzhou Medical College), Zhen Cai(Atrium Health Wake Forest Baptist), Ming Chen(Nanchang University), Guihua Wang(Hengyang Academy of Agricultural Sciences), Yuzhuo Wang(BC Cancer Agency), Zhigang Xu(Chongqing University of Arts and Sciences), R K Manne(Atrium Health Wake Forest Baptist), Haiwei Gu(Arizona State University)
Cited by 6
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer
|Cancer Research|2018|672
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656